Cancer-fighting gene editing tech is one step closer to the market thanks to IP Booster


The German Cancer Research Center boosted their funding for a new potential gene editing technology thanks to the evaluation service they received from IP Booster.

Read more

IP Booster provided an independent, third-party analysis for Oxford University


The deadline to be considered for the third assessment round is early next year. Apply now!

Read more

IP&Coffee session


11th March 2020 - Live presentation of IP Helpdesk's webinars on technology transfer learning to manage your #IP effectively. Register inside here!

Read more